Praxis Precision Medicines, Inc. - Common Stock (NQ:PRAX)

254.54 -5.32 (-2.05%)

Delayed Quote Updated: 10:06 AM EDT, Oct 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Praxis Precision Medicines, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

10 Biggest Price Target Changes For Tuesday ↗

June 07, 2022

Keybanc cut Coupa Software Incorporated (NASDAQ: COUP) price target from $125 to $100. Coupa Software shares rose 0.9% to $72.74 in pre-market trading.

Via Benzinga

95 Biggest Movers From Yesterday ↗

June 07, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II...

Via Benzinga

Praxis Precision Posts Disappointing Data From Depression Study ↗

June 06, 2022

Via Benzinga

Mid-Afternoon Market Update: Dow Turns Lower; DiDi Global Shares Surge ↗

June 06, 2022

U.S. stocks pared gains, with the Dow Jones turning lower toward the end of trading on Monday.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

June 06, 2022

Monday's session saw 84 companies set new 52-week lows.

Via Benzinga

Praxis' PRAX-944 Shows Promising Action In Essential Tremor Patients ↗

May 10, 2022

Via Benzinga

Earnings Scheduled For February 28, 2022 ↗

February 28, 2022

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter. • Praxis Precision Medicine (...

Via Benzinga

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Mid-Day Market Update: Nasdaq Rises 1%; Praxis Precision Medicines Shares Plunge ↗

June 06, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Monday.

Via Benzinga

52 Stocks Moving In Monday's Mid-Day Session ↗

June 06, 2022

Gainers DiDi Global Inc. (NYSE: DIDI) jumped 51.4% to $2.80 after the Chinese government said the company can resume adding new users.

Via Benzinga

ROKU Stock Gets a Lift From New Spanish Streaming Section Espacio Latino ↗

June 06, 2022

Roku (ROKU) stock is gaining on Monday after the streaming company announced a new Spanish language section named Espacio Latino.

Via InvestorPlace

MULN Stock Fans, Mark Your Calendars for June 27 ↗

June 06, 2022

Fans of Mullen Automotive (MULN) stock are going to want to keep an eye on it when June 27 rolls around on a major catalyst.

Via InvestorPlace

Praxis Precision Medicines (PRAX) Stock Plummets on Disappointing Study Results ↗

June 06, 2022

Praxis Precision Medicines (PRAX) stock is taking a beating on Monday following the release of results from a recent clinical trial.

Via InvestorPlace

Mid-Morning Market Update: Markets Open Higher; Science Applications International Earnings Top Views ↗

June 06, 2022

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Monday.

Via Benzinga

41 Stocks Moving In Monday's Mid-Day Session ↗

May 16, 2022

Gainers Data Storage Corporation (NASDAQ: DTST) shares jumped 51.1% to $3.4750 after the company reported better-than-expected Q1 financial results.

Via Benzinga

103 Biggest Movers From Yesterday ↗

May 11, 2022

Gainers

Via Benzinga

The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves ↗

May 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Recap: Praxis Precision Medicine Q4 Earnings ↗

February 28, 2022

Praxis Precision Medicine (NASDAQ:PRAX) reported its Q4 earnings results on Monday, February 28, 2022 at 07:00 AM. Here's what investors need to know about the...

Via Benzinga

The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering ↗

November 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...

Via Benzinga

Topics Retirement

Stocks That Hit 52-Week Lows On Wednesday ↗

April 20, 2022

On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

April 19, 2022

On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was...

Via Benzinga

BofA Initiates Praxis Precision Medical At Buy ↗

August 26, 2021

Praxis Precision Medicines Inc’s (NASDAQ:PRAX) lead ...

Via Benzinga

65 Biggest Movers From Yesterday ↗

January 19, 2022

Gainers Brickell Biotech, Inc. (NASDAQ: BBI) shares jumped 58.6% to settle at $0.33 on Tuesday after HC Wainwright & Co initiated coverage on the stock with a Buy rating and...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021 ↗

August 26, 2021

Upgrades Scotiabank upgraded the previous rating for Enerplus Corp (NYSE:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021 ↗

December 16, 2021

Upgrades According to B of A Securities, the prior rating for Generac Holdings Inc (NYSE:

Via Benzinga

61 Biggest Movers From Yesterday ↗

December 03, 2021

Gainers Jowell Global Ltd. (NASDAQ: JWEL) jumped 25.5% to close at $13.36. Jowell Global recently announced a collaboration with Unilever's Uni-Excubator. Information...

Via Benzinga

Earnings Scheduled For November 3, 2021 ↗

November 03, 2021

Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion....

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗

September 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...

Via Benzinga

66 Biggest Movers From Yesterday ↗

August 18, 2021

Gainers Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 265.5% to close at $15.35 on Tuesday after the company received a written pre-investigational new drug (pre-IND...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.